Newsroom
Sorted by: Latest
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Vasomune Therapeutics, Inc., and AnGes, Inc., Announce US FDA Clearance of Investigational New Drug (IND) Application For Pegevongitide (AV-001) Treatment in Resuscitation of Severely Burned Patients
TORONTO--(BUSINESS WIRE)--FDA clears IND for Pegevongitide (AV-001), a Tie2 agonist targeting vascular leak, to evaluate acute resuscitation in severe burns....
-
Qube Research & Technologies LTD UK Regulatory Announcement: Form 8.3
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: Qube Research & Technologies Limited (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiari...
-
Affinia Therapeutics Granted FDA Fast Track Designation for AFTX-201 as a Treatment for People Living with BAG3-Associated Dilated Cardiomyopathy (DCM)
WALTHAM, Mass.--(BUSINESS WIRE)--Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating cardiovascular diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation (FTD) for AFTX-201, a potential best-in-class investigational genetic medicine for the treatment of BAG3-associated dilated cardiomyopathy (DCM). A...
-
NelsonHall Recognizes LTM as a Leader in GenAI & Process Automation for Banking
MUMBAI, India--(BUSINESS WIRE)--LTM has been recognized as a Leader in the ‘Overall’ market segment in the NelsonHall NEAT Evaluation for GenAI & Process Automation in Banking 2025....
-
NUBURU and Tekne Formalize Ukraine Industrial Deployment Platform Anchored by Operational GRAELION Units; Structured Framework Targets €80–120M Annual Program Scale
DENVER--(BUSINESS WIRE)--NUBURU, Inc. (NYSE American: BURU), a dual-use Defense & Security platform company focused on non-kinetic effects, directed-energy technologies, electronic warfare and software-orchestrated defense systems, today announced that its wholly owned subsidiary, Nuburu Defense LLC, together with Tekne S.p.A. (“Tekne”), has executed a strategic cooperation agreement with Engineering Bureau “BERYL” LLC, an established Ukrainian industrial company currently producing and sup...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 03.03.2026 FGBL.LN IE00BYTH6121 810,944.00 USD 75,167,337.26 92.691 ...
-
First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust United Kingdom AlphaDEX UCITS ETF 03.03.2026 FKUD IE00BD9N0445 118,031.00 GBP 3,479,228.80 29.477 ...
-
Sharon AI Partners with World Wide Technology for Large Scale, High-Performance AI Infrastructure Engineering & Supply Chain Solutions
NEW YORK--(BUSINESS WIRE)--SharonAI Holdings Inc. and its subsidiaries (“Sharon AI”), a leading Australian Neocloud (NASDAQ:SHAZ), today announced it has partnered with World Wide Technology (“WWT”) for the deployment of large-scale high-performance compute infrastructure in Australia and Asia-Pacific. Leveraging more than three decades of global experience delivering complex, mission-critical infrastructure, WWT brings deep capability across AI Factory engineering, global procurement and suppl...
-
ProCap Financial Aggressively Repurchases Shares After Retiring More Than 3% of Outstanding Stock
NEW YORK--(BUSINESS WIRE)--ProCap Financial, Inc. (Nasdaq: BRR), the first publicly traded agentic finance firm, today announced it repurchased 196,043 shares of its common stock in the open market yesterday. The Company has retired more than 3% of its common stock through its stock repurchase plan and BRR’s discount to NAV has nearly been cut in half. “We have already retired more than 3% of the Company’s outstanding stock and continue to vacuum up shares as fast as we are allowed,” said Antho...